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Introduction
Uterine sarcoma represents 1–3% of all female genital
tract neoplasms and 3–7% of all uterine neoplasms.
Uterine sarcoma is generally considered to be an
aggressive tumor with the propensity for local recur-
rence, and widespread and distant metastases early
in the course of the disease process by direct exten-
sion, lymphatic and hematogenous routes [1]. Uterine
sarcomas are characterized by an extremely poor survival
rate for those patients who have extrauterine metastases.
More than 75% of patients died within 1 year of discovery
of their sarcomas [2]. We present a rare case of loin
subcutaneous epithelioid sarcoma originating from the
multiple metastases of uterine leiomyosarcoma.
Case Report
A 54-year-old postmenopausal woman, gravida 6, para
6, presented to the general surgery outpatient
department (OPD) in August 2002, suffering from
progressive enlargement of a right loin subcutaneous
mass and weight loss of 2 kg. Loin mass excisional
surgery was performed on August 6, 2002, and the
associated pathology report was consistent with a
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diagnosis of epithelioid sarcoma (Figure 1). Sharp
intermittent lower abdominal pain, low grade fever and
back pain were noted on the fifth day after this surgery.
She was referred to the gynecology OPD for further
evaluation.
Pelvic examination revealed a 16-week gestational
size uterus with nodular contours. Transvaginal
sonography revealed an enlarged uterus (with two fi-
broids measuring approximately 7.3 = 7.3 = 7 cm and
6.7 = 6.7 = 6.5 cm) and low resistant vascular flow.
Chest X-ray revealed multiple nodules occupying the
middle and lower left lung fields, suspected to be
metastatic lesions. Laparotomy was arranged for August
26, 2002. Intraoperatively, a uterus measuring 15 =
10 = 8 cm in size, with grossly normal adnexa, was first
noted. There was 100 mL of bloody ascites in the
abdominal cavity, a sample of which was obtained for
cytologic examination. Surgical specimens of multiple
nodules on the liver surface, mesentery, small intes-
tinal surface, omentum and sub-diaphragm were also
sampled for pathologic examination. Total abdom-
inal hysterectomy (TAH) and bilateral salpingo-
oophorectomy (BSO) were performed because uterine
fibroid was the most suspicious originating site of these
metastatic lesions.
The uterine specimen grossly revealed a large
intramural mass protruding into the lower endometrial
cavity with polypoid tumor growth and massive
hemorrhagic sites. Microscopic examination of the
polypoid sites revealed marked atypia and frequent
mitoses, exhibiting characteristics similar to leiomyo-
sarcoma (Figure 2). Immunohistochemical staining for
this lesion was positive for smooth-muscle actin and
vimentin, but negative for cytokeratin, desmin and
progesterone receptor. Some individual lesions revealed
intravascular growth or permeation. There were no
abnormal pathologic findings in the endometrium, cer-
vix, fallopian tubes and ovaries. Poorly differentiated
leiomyosarcoma with epithelioid features and multiple
metastases to the right loin as well as other organs were
confirmed by the pathologist.
After laparotomy, the abdominal distension and
pain continued with little improvement. Shortness of
breath was noted within 1 week after surgery, and
multiple nodules occupying bilateral lung fields were
found on chest X-ray. She was transferred to the inten-
sive care unit due to acute respiratory distress caused
by bilateral pleural effusion as confirmed by chest
sonography. Pig-tail catheter placement into the pleural
cavity was performed for the drainage of bilateral pleural
effusion, but there were no signs of improvement. She
died on September 17, 2002 (3 weeks after laparotomy)
as a result of multiple metastases of leiomyosarcoma in
both lung fields and respiratory failure.
Discussion
Uterine sarcoma accounts for 1–3% of all female geni-
tal tract neoplasms and 3–7% of uterine neoplasms.
Histologically, they are heterogeneous and can be
classified into three major groups: uterine leiomyo-
sarcoma (ULS), mixed mesodermal tumor (MMT) and
endometrial stromal sarcoma (ESS). ULS accounts for
approximately 40% of all uterine sarcomas [3]. The
distribution of metastatic sites in 22 patients treated for
uterine sarcoma at University of Michigan Hospitals is
shown in the Table [2]. The majority of patients was
diagnosed with MMT (11/22, 50%), followed by ESS
(6/22, 27%) and ULS (5/22, 23%). Most patients had
Figure 1. Microscopic findings of epithelioid sarcoma of the
right loin skin: (A) high cellularity is seen (hematoxylin & eosin,
= 40); (B) atypical mitosis can be identified (hematoxylin &
eosin, = 400).
  A
Figure 2. Microscopic findings of uterine leiomyosarcoma:
(A) high cellularity is seen in the upper area of the slide, with
central necrosis in the right lower area (hematoxylin & eosin,
= 40); (B) there are at least three atypical mitosis cells per
high-powered field (hematoxylin & eosin, = 400).
  A
  B
  B
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multiple metastases that involved the pelvic perito-
neum and upper abdominal peritoneum (including
diaphragm). Lymph nodes (retroperitoneal) were
involved in 13 patients (59%). Ten patients (45%) had
disease limited to the abdomen and pelvis, while 12
(55%) had disease above the diaphragm. Only one pa-
tient (5%) with disease limited to the pelvis died. The
most common site of the disease above the diaphragm
was the lung. Uterine sarcomas spread by direct ex-
tension, lymphatic and hematogenous routes. It was
readily apparent that widespread and distant metasta-
ses occurred early in the course of the disease process,
which rendered the vast majority of treatment failures.
The common causes of death included obstructive renal
and respiratory failures as a result of tumor replacement
or pneumonia. Patients who had uterine sarcomas with
extrauterine metastases had extremely poor survival;
more than 75% of the patients died within 1 year of
discovery of their sarcoma.
The prognosis of uterine sarcoma is notorious for its
difficult determination. The frequent development of
distant metastases is the main reason for the poor
survival observed in uterine sarcoma compared with
other uterine malignancies [1]. ULS is usually diagnosed
when it is already in the advanced stages or accidentally
at TAH. The diagnosis of ULS relies heavily on the
interpretation of microscopic findings [3]. ULS is rarely
diagnosed preoperatively [2]. Goto et al reported a
new preoperative assessment that combines dyna-
mic magnetic resonance imaging (with Gd-DTPA
enhancement) and serum determination of lactate
dehydrogenase (isozymes) [4]. This preoperative
combinational assessment can assist in the clinical
diagnosis to differentiate ULS from degenerative
leiomyoma. Clinical cases of other less commonly ob-
served metastatic sites of ULS have also been reported
in the literature, including external soft tissues [4],
submandibular gland [5], heart [6], skin [7], parotid
gland [8], thyroid gland [9] and tongue [10]. Broderick
and Connors reported a rare case of ULS that meta-
stasized as a primary sarcoma of the skin located on
the patient’s left toe and diagnosed 10 years after
hysterectomy [7]. Fleming et al reported that ULS
accounted for about 2.3% of all superficial soft tissue
sarcomas, and 67% of these ULS were located in the
retroperitoneum and mesentery [2].
The present report demonstrates a rare case of loin
subcutaneous epithelioid sarcoma originating from the
multiple metastases of ULS. The abrupt appearance of
skin or subcutaneous nodules should prompt the
clinician to consider the possibility of metastatic disease
even in patients with no known history of malignant
neoplasm. The sites of origin of cutaneous metastases
are breast (50%), stomach (15–31%), lung (12%), uterus
Table. Distribution of metastatic sites in 22 patients treated for uterine sarcoma at University of Michigan
Hospitals [2]
ULS (n = 5) MMT (n = 11) ESS (n = 6) Total (n = 22)
Pelvis
   Pelvic peritoneum 5 10 6 21
   Vagina 2 7 6 15
   Retroperitoneal nodes 2 7 4 13
   Bladder muscularis 1 2 1 4
   Rectal muscularis 0 2 0 2
Upper abdomen
   Upper abdominal peritoneum, including diaphragm 4 11 6 21
   Serosa of bowel 2 8 6 16
   Parenchymal liver 1 6 2 9
   Pancreas 0 3 1 4
   Kidney 1 2 0 3
   Spleen 1 1 1 3
   Bowel muscularis 0 2 0 2
   Adrenal 0 0 1 1
Extra-abdominal
   Lung 1 7 2 10
   Esophagus 1 1 0 2
   Breast 1 0 0 1
   Bone 0 1 0 1
   Brain 1 1 0 2
ESS = endometrial stromal sarcoma; MMT = mixed mesodermal tumor; ULS = uterine leiomyosarcoma.
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(9%) and kidney (9%). The appearance of cutaneous
metastases portends a rapid clinical deterioration with
fatal termination. The duration of life from the time of
the appearance of a metastatic skin nodule to death
averages 3 months [7]. The recommended primary
treatment for uterine sarcoma is TAH and BSO in the
early stage. The inclusion of regional pelvic lympha-
denectomy as part of primary treatment remains
inconclusive and debatable as there is no evidence that
lymphadenectomy affects survival or cure rates. The role
of adjuvant therapy (postoperative radiation or chemo-
therapy) is controversial. Despite recent advances in
the implementation of chemotherapy in gynecologic
oncology, the chemotherapeutic methods for ULS have
not improved the life expectancies of patients in the last
two decades [11]. The most effective treatment of
ULS remains surgical removal of the tumor in the early
stage [12].
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